TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc. (HURA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HURA · as of Jun 9, 2026
Key Statistics
Explore TuHURA Biosciences, Inc. Data
hura stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
hura competitorsHURA
ABOS
AGEN
CGTX
INO
IRDStock Performance
Full HistoryAbout TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies des…
what is tuhura biosciences, inc. · hura stock overview · tuhura biosciences, inc. company profile · who is tuhura biosciences, inc. ceo · hura NASDAQ · tuhura biosciences, inc. headquarters · tuhura biosciences, inc. business segments
About Stock Overview & Key Data
TuHURA Biosciences, Inc. (HURA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 22, 2013. As of the latest trading session, HURA stock price is $2.04, with a market capitalization of $130.2M. The stock has returned -28.99% over the past 12 months and +170.25% year-to-date.
According to 2 Wall Street analysts, the consensus rating for TuHURA Biosciences, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, TuHURA Biosciences, Inc. reported revenue of — and net income of -$30.1M. For detailed data — including TuHURA Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, TuHURA Biosciences, Inc. (HURA) stock price is $2.04. The stock is traded on NASDAQ under the ticker symbol HURA. The 52-week range is $0.41 – $3.90.